Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Conference Roundup > Streamline procedure with phacoemulsification significantly reduces IOP in OAG
  • Conference Roundup

Streamline procedure with phacoemulsification significantly reduces IOP in OAG

Ophthalmology 360

Mean intraocular pressure (IOP) was significantly reduced in patients with mild to severe open angle glaucoma after incisional goniotomies and canaloplasty with the Streamline surgical system when combined with phacoemulsification, according to a study presented at the 2023 American Glaucoma Society Annual Meeting.

In this retrospective case series, 38 eyes from 26 patients with mild to severe open angle glaucoma who underwent the Streamline procedure at the time of phacoemulsification cataract surgery were analyzed. Most patients had primary open angle glaucoma (82%) and mild disease (68%). There was a baseline mean IOP of 16.1 mmHg and a mean baseline of 1.3 medications.

Surgical success was defined as an IOP reduction of ≥20% and/or the reduction of ≥1 topical glaucoma medication.

At 6 months after surgery, the surgical success rate was 66.7%. Baseline mean IOP decreased to 13.7 mmHg at 1 month postoperatively, to 13.7 mmHg at 3 months postoperatively, and to 15.4 mmHg at 6 months postoperatively (P < 0.001 for all).

Medication use also decreased at 1 month postoperatively and was sustained at 3 and 6 months postoperatively.

A single eye experienced an IOP spike, which was treated with topical medications. No other procedure-related complications were reported.

Reference
Temple H, et al. Clinical Outcomes With the Streamline Surgical System in Mild to Severe Open-Angle Glaucoma. Presented at: 2023 American Glaucoma Society Annual Meeting.

Share

Related Content

  • Glaucoma

Study finds significant IOP reductions with iDose TR and MIGS procedures

  • Glaucoma

EyeValve device lowers IOP and maintains control for 9 months in first-in-human study

  • Glaucoma

GLP-1 therapies may offer potential benefits in glaucoma

  • Glaucoma

PreserFlo MicroShunt shows short-term benefit in refractory childhood glaucoma

  • Glaucoma

iStent adoption rises as surgeons treat glaucoma earlier

  • Glaucoma

Review finds low adverse event rates for glaucoma stents

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon